Rapporten
Dybdegående analyser af virksomhedsfinansiering, vækststrategier og markedsindsigt fra verdens mest innovative virksomheder
196 rapporter og tæller
Denali Therapeutics raises $217M Series C at $5B valuation
Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...
Denali Therapeutics Raises $217M in Series C
Denali Therapeutics, a Biotech company based in 161 Oyster Point Boulevard, South San Francisco, CA 94080, has raised $217M in Series C at a $5B valuation led by Baillie Gifford, Redmile Group, Vivo Capital, GV, Fidelity.
Arnatar Therapeutics raises $52M Series A
Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...
Strand Therapeutics raises $153M Series B
Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...
Seres Therapeutics raises $113M Series E at $450M valuation
Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...
Crystalys Therapeutics raises $205M Series B at $900M valuation
Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...
Kailera Therapeutics raises $400M Series A at $1.5B valuation
Kailera Therapeutics raises $400M in Series A at $1.5B valuation. Developing obesity therapeutics with acquired pipeline...
Expedition Therapeutics raises $165M Series B at $850M valuation
Expedition Therapeutics raises $165M in Series B at $850M valuation. Developing novel therapeutics for cardiometabolic diseases...
Candid Therapeutics raises $370M Series A at $1.2B valuation
Candid Therapeutics raises $370M in Series A at $1.2B valuation. Developing novel therapeutics for autoimmune diseases...
Viser 9 rapporter • Side 1 • Kategori: all
Hold dig foran markedet
Få ugentlig indsigt leveret til din indbakke. Ingen spam, kun intelligens.